Arkolith/Insider Trading/INDV/Form 4

Preblick Ryan

Chief Financial OfficerIndivior Pharmaceuticals, Inc. (INDV) · full profile →Form 4 · filed Jun 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2026Sell(S)36K$37.70$1.4M285K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002014866-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML